ABCAF yields 1876.17% · PFE yields 6.13%● Live data
📍 ABCAF pulled ahead of the other in Year 1
Combined, ABCAF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ABCAF + PFE for your $10,000?
Athabasca Minerals Inc. develops and supplies aggregates and industrial minerals in Canada. The company operates through four segments: AMI Aggregates, AMI Silica, AMI RockChain, and TerraShift. It holds interest in the Richardson Quarry project comprising three metallic and industrial mineral leases covering an area of 3,904 hectares located to the north of Fort McMurray region. The company also holds interests in the Montney In-Basin project situated in the vicinity of Dawson Creek, Alberta and Fort St. John, British Columbia; the Duvernay project located in Alberta; and Firebag silica sand deposit located north of Fort McMurray, Alberta. In addition, it constructs, operates, and manages the Coffey Lake Public Pit located in north of Fort McMurray, Alberta. Further, it operates RockChain, a digital platform to provide integrated supply and transportation solutions industrial and construction markets; and offers engineering and project services, as well as proprietary technology applications, such as TerraMaps. The company serves multi-national companies, governmental bodies, and small and private companies in infrastructure, construction, power generation, aggregates, forestry, and energy sectors. The company was incorporated in 2006 and is headquartered in Edmonton, Canada.
Full ABCAF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.